Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

British American Tobacco share price: where next amid US vaping crackdown?

The tobacco company pleased investors last week, announcing that it expects to deliver a strong performance in 2019 despite US regulators cracking down on vaping products.

BAT British American Tobacco Source: Bloomberg

British American Tobacco (BAT) told investors last week that, despite US regulators cracking down on vaping products, it still expects to end 2019 on a high.

‘We expect to deliver a strong performance in 2019, building on the good progress we made in the first half,’ BAT CEO Jack Bowles said. ‘We are on track for a strong year.’

The company said that it expects full-year adjusted revenue to hit the high end of its 3% - 5% guidance range and operating profit at the top of its 5% - 7% range, with combustibles offsetting the slowdown in sales in the US vaping market.

The news helped send BAT’s share price more than 3% higher, with the stock closing at £30.50 on Monday.

Looking to trade BAT and other tobacco stocks? Open a live or demo account with IG.

Jefferies optimistic about BAT’s price trajectory

Analysts at Jefferies reiterated their ‘buy’ rating for the stock in November and issued a target price of £48, which represents a potential upside for the stock of 57%.

Liberum Capital is less upbeat about the stock’s price trajectory, however, reiterating its ‘buy’ rating and issuing a target price of £31.70 a share.

However, analysts at DZ Bank reiterated their ‘sell’ rating and issued a price target of £26.50, representing a potential downside of -13%.

You can go long or short BAT with IG using derivatives like CFDs.

BAT ‘well placed to succeed’ in strong regulatory environment

BAT believes that issues around vaping that have led to a clampdown in the US will ultimately help the company moving forward.

‘Increased investment and new product launches are delivering good New Category revenue growth in H2, despite the recent slowdown in the US vapour market,’ Bowles said.

‘We believe that the issues around vaping in the US should lead to a better and stronger regulatory environment in which we are well placed to succeed.’

After a series of deaths and respiratory illnesses were linked to vaping, several US states moved to ban the sale of e-cigarettes and other vaping-related products.

Earlier this year, BAT’s smaller rival Imperial Brands said that its vaping business has seen sales growth suffer due to the crackdown by US regulators.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.